Biblio Discovery — Demo Discovery Service

1,624 results

Showing 1–20 · 0.21 seconds · RSS

Journal

Harm Reduction Journal

Scopus

ISSN 1477-7517 · BMC · 1,624 articles in the index

  1. Journal Article

    All-cause mortality and overdose deaths among 4192 people who inject drugs in Stockholm: a 10-year register-based cohort study

    E. Holmén; A. Hammarberg; M. Kåberg

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background People who inject drugs (PWID) face premature mortality, particularly from opioid overdose. In Sweden, harm reduction has expanded, including increased access to opioid agonist therapy (OAT) and the 2018 introduction of Take-Home Naloxone (THN). This study aimed to examine…

  2. Journal Article

    Reducing gambling harm through digital self-help intervention: a pilot study in mild to moderate gambling disorder

    Maayan Nagar; Keren Gueta; Trevor van Mierlo

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Gambling Disorder (GD) is associated with significant personal and social harms, yet most individuals, especially those with mild to moderate symptoms, do not seek treatment. Online interventions offer an accessible and resource-efficient approach, but their cultural fit and…

  3. Journal Article

    Police officers’ stigmatizing attitudes toward people who use drugs: implications for support of deflection

    Jessica Reichert; Kaitlin Martins; Bruce Taylor et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Police deflection programs represent a promising public health strategy for addressing substance use disorders (SUDs) and diverting people who use drugs (PWUD) from the criminal legal system. These programs offer support to individuals frequently encountered by law enforcement, connecting…

  4. Journal Article

    ‘A fine line between euphoria and death’: a qualitative study exploring gamma-hydroxybutyrate (GHB) use among people who identify as heterosexual living in Australia

    Keaton Hudson-Buhagiar; Jonathan Brett; Alanah Spillane et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Harms associated with gamma-hydroxybutyrate (GHB) use have increased recently in Australia. However, research predominantly focuses on the experience of GHB use among LGBTQ + populations. Non-prescribed GHB use has not been well described in heterosexual populations. Research to…

  5. Journal Article

    Realist review of managed alcohol programmes for people experiencing alcohol dependence and homelessness: what works, for whom, and in what circumstances?

    Hannah Carver; Emma King; Jessica Greenhalgh et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Introduction People experiencing homelessness and alcohol dependence are vulnerable to a range of harms, and existing treatment options, which are often abstinence-based, are inadequate for this group because they may be unavailable, unsuitable, or not aligned with goals. Abstinence-based…

  6. Journal Article

    From dust till dawn: patterns, motives, and risks of using smokable synthetic cathinones

    Antonia Bendau; Paale Bournot; Felix Betzler et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Synthetic cathinones that are primarily smoked—such as pyrovalerone-type compounds, including MDPV, MDPHP, α-PHP, and α-PHiP, often referred to as “Monkey Dust”—have raised growing concern in clinical and harm reduction contexts due to their association with severe adverse…

  7. Journal Article

    Street drug monitoring with networked spectrometers powered by machine learning: a pilot study in Ontario, Canada

    Elnaz Aliyari; Cameron Brown; Megan Van Boheemen et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Drug-checking services (DCS) provide people who use drugs (PWUD) with crucial information concerning the substances they may consume. The intent of DCS is to reduce harms potentially associated with those substances, by providing evidence-based information about the contents of said…

  8. Journal Article

    “He will still know where I live”: harm reduction for women who use drugs and experience Gender-Based violence

    Anabel Ramírez-López; Carmen Meneses-Falcón; Nuria Romo-Avilés

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Treatment for substance use disorders in Spain has traditionally been abstinence-focused and developed from an androcentric perspective, failing to address the specific needs of women who use drugs. Although abstinence-based models continue to predominate, cities such as Madrid…

  9. Journal Article

    Chiral sensitivity of medetomidine lateral flow immunoassay test strips

    Anita Amate; Marya Lieberman

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Medetomidine has recently emerged in the illicit drug supply in the United States, and lateral flow immunoassay test strips are an inexpensive and easy-to-use field screening option for detecting this highly potent sedative. However, the drug is chiral, and the response of test strips to…

  10. Journal Article

    Evaluating the implementation and impact of harm reduction vending machines in veterans supportive housing settings: a mixed-methods study protocol

    Tessa Rife-Pennington; Michael P. Douglas; Nikki Kalani Apana et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Lack of access to sterile supplies among people who use drugs contributes to increased rates of infectious disease transmission, including human immunodeficiency virus, hepatitis C virus, and sexually transmitted infections. People residing in California, United States Veterans…

  11. Journal Article

    Harm reduction engagement and ongoing opioid use among adults receiving methadone or buprenorphine in Philadelphia

    William Brincheiro; Nolan Chiles; William Jangro et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Opioid Use Disorder (OUD), a chronic condition with significant health and social consequences, has been intensified by synthetic opioids such as fentanyl. Although medications for OUD (MOUD) reduce mortality and improve treatment retention, many individuals continue to engage…

  12. Journal Article

    Practical considerations for residential-managed alcohol programs: lessons from Ottawa Inner City Health

    Aliza Moledina; Daniel Myran; Rakesh Patel et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Alcohol Use Disorder (AUD) is a leading contributor to global morbidity and mortality, disproportionately affecting people experiencing homelessness. Managed Alcohol Programs (MAPs) represent a harm reduction-based strategy for individuals with severe AUD and homelessness…

  13. Journal Article

    Expanding access to harm reduction in rural communities through community-informed public health vending machines

    Lori Ann Eldridge; Christian Dotson; Lauren Harrell et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background The opioid epidemic continues to disproportionately impact rural communities across the United States, where structural barriers, including geographic isolation, limited public health infrastructure, and heightened stigma, restrict access to harm reduction services. Public…

  14. Journal Article

    Energy drink consumption among Kabul University students: a cross-sectional study of prevalence, patterns, awareness, and adverse health effects

    Ershad Ahmad Mushkani; Fahima Hamidy; Tawfiq Ahmad Mushkani et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Energy drinks are stimulant-containing beverages, primarily formulated with caffeine and marketed to enhance mental and physical performance. Unlike coffee, tea, or caffeinated soft drinks, these products are specifically designed as functional stimulants. Purpose This study…

  15. Journal Article

    Perspectives on hepatitis A and B screening and immunization at a syringe services program: a mixed-methods study

    Subul Malik; Marina Plesons; Monica Faraldo et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background People who inject drugs (PWID) are at increased risk for viral hepatitis, yet hepatitis A virus (HAV) and hepatitis B virus (HBV) screening and immunization rates remain low. Although offering HAV and HBV services at syringe services programs (SSPs) is effective, few U.S. SSPs…

  16. Journal Article

    Emergency department-based testing for xylazine and other novel psychoactive substances in Central Alabama: a feasibility study

    William Bradford; Daniel Dye; Rebecca Jensen et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Alabama, like other states in the Deep South, lacks comprehensive testing for novel psychoactive substances (NPS) and adulterants like xylazine, leaving gaps in the detection of drug supply changes. From August 2024 to July 2025, we implemented an active testing approach at an emergency…

  17. Journal Article

    Clinical outcomes from a mid-western opioid treatment program during covid-19 emergency regulations: a brief report on the effect of tetrahydrocannabinol (THC) use on take home methadone access

    Erin T. LaCourt; Oranu Ibekie; Charles C. Dike et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract The study examines whether tetrahydrocannabinol (THC) use alone affected sustainability of weekly take-home methadone medication among a small sample of 33 patients attending a single opioid treatment program, under special exception by state and federal governments during the Covid-19…

  18. Journal Article

    ‘The power of universality is that everybody is treated the same’: Exploring the possibilities and limitations of a universal approach to stigma reduction among BBV/STI sector stakeholders in Australia

    Elena Cama; Emily Lenton; Adrian Farrugia et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background There are increasing calls for cross-cutting approaches to reducing stigma in health systems that do not silo specific identities, conditions, or practices. In our previous work, we proposed a ‘universal precautions’ approach to addressing stigma and its negative effects…

  19. Journal Article

    Safer inhalation devices: a rapid Health Impact Assessment of a harm reduction pilot for people who smoke crack cocaine

    Kathryn Ashton; Benjamin Gray; Rick Lines et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background People who smoke crack cocaine face significant health risks, including communicable diseases and damage to respiratory health, particularly when using shared or homemade equipment. Despite this, there are currently no targeted harm reduction interventions in Wales for this…

  20. Journal Article

    ‘It wasn’t to get high; it was just to get by’: experiences of patients who use fentanyl during methadone treatment and opportunities for improving care in Vermont and New Hampshire

    Jesse S. Boggis; Elizabeth C. Saunders; Lisa A. Marsch et al.

    Harm Reduction Journal, Vol. 23 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background In March 2020, federal regulations were updated to improve access to methadone for people with opioid use disorder (OUD) during COVID-19, and in February 2024, these COVID-19 flexibilities were further updated and made permanent. During the same time, high rates of fentanyl use…

Showing at most 50 pages. Narrow your search with filters for more specific results.